Regenosca

Lausanne, Switzerland

Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair.

$1.1M raised

Jul 2024

Pre-Seed

Top Investors

MassChallengeVenture KickFoundation for Innovation and Technology (FIT)Business Angels Switzerland (BAS)

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Regenosca raised?

Regenosca has raised $1.1M in total funding. The most recent round was Pre-Seed. The last funding was announced in July 2024.

Who are Regenosca's investors?

Regenosca's investors include MassChallenge, Venture Kick, Foundation for Innovation and Technology (FIT), Business Angels Switzerland (BAS).

Where is Regenosca headquartered?

Regenosca is headquartered in Lausanne, Switzerland.

What does Regenosca do?

Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair.

What stage is Regenosca at?

Regenosca is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 22, 2024.

MLA

"Regenosca — Funding & Investors." VCBacked, July 22, 2024, https://www.vcbacked.co/company/regenosca. Accessed June 4, 2026.

APA

VCBacked. (2024). Regenosca — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/regenosca

Wikipedia (cite web)

{{cite web |title=Regenosca — Funding & Investors |url=https://www.vcbacked.co/company/regenosca |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 22, 2024.